Cargando…

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists

Macrocycles were designed to antagonize the protein–protein interaction p53-MDM2 based on the three-finger pharmacophore F(19)W(23)L(25). The synthesis was accomplished by a rapid, one-pot synthesis of indole-based macrocycles based on Ugi macrocyclization. The reaction of 12 different α,ω-amino aci...

Descripción completa

Detalles Bibliográficos
Autores principales: Neochoritis, Constantinos G, Kazemi Miraki, Maryam, Abdelraheem, Eman M M, Surmiak, Ewa, Zarganes-Tzitzikas, Tryfon, Łabuzek, Beata, Holak, Tad A, Dömling, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404402/
https://www.ncbi.nlm.nih.gov/pubmed/30873235
http://dx.doi.org/10.3762/bjoc.15.45
Descripción
Sumario:Macrocycles were designed to antagonize the protein–protein interaction p53-MDM2 based on the three-finger pharmacophore F(19)W(23)L(25). The synthesis was accomplished by a rapid, one-pot synthesis of indole-based macrocycles based on Ugi macrocyclization. The reaction of 12 different α,ω-amino acids and different indole-3-carboxaldehyde derivatives afforded a unique library of macrocycles otherwise difficult to access. Screening of the library for p53-MDM2 inhibition by fluorescence polarization and (1)H,(15)N HSQC NMR measurements confirm MDM2 binding.